Back

Association between clinical ischemic risk and thrombogenicity phenotype and their prognostic prediction in patients undergoing percutaneous coronary intervention

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute myocardial infarction: innovative approaches to management and prediction Thrombosis, Platelets, and Coagulation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Daeung Ohn

Eunpyeong St. Marys Hospital, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Drug-coated balloon versus drug-eluting stent revascularization in the treatment of de novo acute myocardial infarction
Professor A. Her (Chuncheon, KR)
Abstract Slides Video
Presentation thumbnail
Microdosing of alteplase leads to thrombolysis in an in vitro flow model of cardiac microvascular obstruction
Doctor A. Milusev (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Impact of stress hyperglycemia ratio on periprocedural myocardial infarction in patients with NSTEMI
Doctor C. Asta (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Supersaturated oxygen therapy in patients with acute anterior myocardial infarction reduces infarct size
Professor A. Schaefer (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Platelet-large cell ratio predicts no-reflow in patients undergoing primary coronary angioplasty for ST-segment elevation myocardial infarction
Professor A. Scridon (Targu Mures, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Acute myocardial infarction: innovative approaches to management and prediction

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Differential prognostic significance of platelet reactivity based on ischemic risk after percutaneous coronary intervention
thumbnail
Congress Presentation
Intensity of dual antiplatelet therapy based on thrombotic and bleeding risks after coronary stenting
thumbnail
Congress Presentation
Pattern of dual antiplatelet use and 12-month outcomes stratified by bleeding and ischemic risk in acute coronary syndrome patients undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources